POST-ERCP PANCREATITIS

Clinical trials for POST-ERCP PANCREATITIS explained in plain language.

Never miss a new study

Get alerted when new POST-ERCP PANCREATITIS trials appear

Sign up with your email to follow new studies for POST-ERCP PANCREATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Completed 1

Half the dose, same protection? trial aims to make common procedure safer

Prevention Recruiting now

This study is testing if a lower dose of a rectal anti-inflammatory drug (indomethacin) works as well as the standard dose to prevent painful pancreas inflammation after an ERCP procedure. Over 1,300 adults scheduled for ERCP will be randomly given either the low or standard dose…

Matched conditions: POST-ERCP PANCREATITIS

Phase: PHASE4 • Sponsor: Changhai Hospital • Aim: Prevention

Last updated Mar 30, 2026 14:35 UTC

POST-ERCP PANCREATITIS

Get alerted when new POST-ERCP PANCREATITIS trials appear

Half the dose, same protection? trial aims to make common procedure safer